Drug Profile
Sofigatran
Alternative Names: MCC-977Latest Information Update: 01 Feb 2008
Price :
$50
*
At a glance
- Originator Mitsubishi Chemical
- Class Antithrombotics
- Mechanism of Action Thrombin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Deep vein thrombosis
Most Recent Events
- 01 Oct 2007 Mitsubishi Pharma Corporation merged with Tanabe Seiyaku Co. Ltd to form Mitsubishi Tanabe Pharma Corporation
- 06 Jun 2006 This compound is still in active development
- 06 Dec 2004 This programme is still in active development